Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Name: Αlpha¹ Rigor Record — Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Item: Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Rating: 96
Author: Αlpha¹

Durbin AP, Van Wesenbeeck L, Pierce KK, Herrera-Taracena G, Ebone L, Buelens A, Lutton P, Sabundayo BP, Van Eygen V, De Clerck K, Fetter I, Voge NV, Fang X, Goeyvaerts N, Vandendijck Y, Mayfield J, Lenz O, De Meyer S, Kakuda TN, He H, Amaro-Carambot E, Draghia-Akli R, Carmolli M, De Marez T, Whitehead SS, Van Loock M, Rasschaert F

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 3.25★ (Adequate), 0 critical, 3 high issues for “Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

3.25 / 5

Adequate — real issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern−0.5★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingData & code availability partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

No data or code availability links were detected to verify.

Problems surfaced4 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions2

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Treatment effect not shown to be clinically meaningfulAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-conducted phase 2a randomized, double-blind, placebo-controlled CHIM trial with rigorous design, clear reporting of ethics, biological variables, and key resources. The main weakness is the lack of a data availability statement and code sharing, which limits transparency and reproducibility.

Both reviewers independently scored all eight dimensions and agreed on all statuses. The study type is interventional (CHIM trial). Non-applicable sub-criteria (e.g., animal housing, cell line authentication) were excluded from scoring.

4 major claims checked against the paper's own evidence: all adequately supported.

Premise concern: surrogate not validated for clinical benefit; effect size not shown to be clinically meaningful.

Recomputed 1 test: 1 consistent, 0 inconsistent; 1 via agent-written checks.

1 integrity concern flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites the global burden of dengue, limitations of current vaccines, and the mechanism of mosnodenvir. It acknowledges the need for antiviral prophylaxis and builds a logical rationale for the study. Limitations of prior research are implicitly addressed by noting the lack of antiviral options and the need for field confirmation.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedINADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with adequate prior work and rationale.

Evidence

direct quote[Introduction, paragraph 1-3]

“Dengue is a growing public health threat, with about half of the world population being considered at risk by the World Health Organization.”